# Effects of the Polar Fraction of Lophocereus schottii on Gene Expression and Hepatocyte Proliferation in a Wistar Rat Model of Hepatocellular Carcinoma

**Authors:** Marina Campos-Valdez, Jaime Sánchez-Meza, Arturo Orozco-Barocio, José A. Domínguez-Rosales, Juliana Marisol Godínez-Rubí, Sarai C. Rodríguez-Reyes, Erika Martínez-López, Miriam R. Bueno-Topete, Manuel A. Castro-García, Guillermo M. Zúñiga-González, Daniel Ortuño-Sahagún, Laura V. Sánchez-Orozco

PMC · DOI: 10.3390/ijms26199788 · International Journal of Molecular Sciences · 2025-10-08

## TL;DR

This study explores how a cactus extract affects gene activity and liver cell growth in rats with liver cancer, finding some effects depending on when it's given.

## Contribution

The study reveals the timing-dependent impact of LsPF on gene modulation and hepatocyte proliferation in HCC.

## Key findings

- LsPF modulated gene expression related to liver carcinogenesis when administered after seven weeks of HCC induction.
- Co-administration of LsPF with damage treatment reduced the number of mitotic hepatocytes.
- LsPF did not significantly improve macroscopic, biochemical, or histologic outcomes in HCC rats.

## Abstract

Hepatocellular carcinoma (HCC) remains a major global health problem for which there are few effective treatments. Phytochemicals from natural sources, such as those found in cacti, exhibit chemoprotective and hepatoprotective properties. In this study, the effect of the polar fraction of Lophocereus schottii (LsPF) was investigated in a Wistar rat model of HCC induced by weekly administration of diethylnitrosamine (DEN, 50 mg/kg, i.p.) and 2-acetylaminofluorene (2-AAF, 25 mg/kg, i.g.) for 13 weeks. LsPF (50 mg/kg, i.g., three times per week) was administered either concurrently with HCC induction beginning in the first week or after seven weeks of HCC induction. LsPF did not lead to a significant improvement in macroscopic, biochemical or histologic results. However, when LsPF was administered after 7 weeks of HCC induction, it modulated the expression of genes related to liver carcinogenesis, including SOD, CAT, CYP2E1, TGFB1, AFP, and COL1A. In addition, co-administration of LsPF along with the damage treatment decreased the number of mitotic hepatocytes. These results suggest that LsPF can modulate gene expression and hepatocyte proliferation in HCC, with efficacy depending on the timing of administration, disease stage, and administration method. Further studies are needed to optimize its therapeutic potential.

## Linked entities

- **Genes:** SOD1 (superoxide dismutase 1) [NCBI Gene 6647], CAT (catalase) [NCBI Gene 847], CYP2E1 (cytochrome P450 family 2 subfamily E member 1) [NCBI Gene 1571], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], AFP (alpha fetoprotein) [NCBI Gene 174], COL2a (CONSTANS-like 2a) [NCBI Gene 100301885]
- **Chemicals:** diethylnitrosamine (PubChem CID 5921), 2-acetylaminofluorene (PubChem CID 5897)
- **Diseases:** Hepatocellular Carcinoma (MONDO:0007256), HCC (MONDO:0007256)

## Full-text entities

- **Diseases:** HCC (MESH:D006528), liver carcinogenesis (MESH:D063646)
- **Chemicals:** 2-AAF (MESH:D015073), LsPF (-), DEN (MESH:D004052)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Lophocereus schottii (species) [taxon 153875]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12524451/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12524451/full.md

## References

105 references — full list in the complete paper: https://tomesphere.com/paper/PMC12524451/full.md

---
Source: https://tomesphere.com/paper/PMC12524451